Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. (Q45042550)
Jump to navigation
Jump to search
scientific article published on 2 September 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. |
scientific article published on 2 September 2004 |
Statements
1 reference
Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412. (English)
1 reference
Donna Neuberg
1 reference
Richard M Stone
1 reference
Daniel J DeAngelo
1 reference
Virginia Klimek
1 reference
Ilene Galinsky
1 reference
Eli Estey
1 reference
Stephen D Nimer
1 reference
Wilson Grandin
1 reference
David Lebwohl
1 reference
Yanfeng Wang
1 reference
Pamela Cohen
1 reference
Edward A Fox
1 reference
Jennifer Clark
1 reference
D Gary Gilliland
1 reference
James D Griffin
1 reference
2 September 2004
1 reference
1 reference
Identifiers
1 reference